9 results
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
to 1:1 F:M • Clinical ... , SCLE-DIL (terbinafine ... 40, F:M 9:1 • Clinical ... Usual therapeutic management ... of SLEEvolution
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary
 • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
Diagnosis and Management ... 40, F:M 9:1 • Clinical ... versus DIL • ... life-threatening • Treatment ... of SLEEvolution
Septic Arthritis - Diagnosis and Management Summary
Clinical Exam: hot, swollen, pain with passive AND active ROM
Diagnosis and Management ... Summary Clinical ... count, and crystal evaluation ... : admission for ... MH/CCF/CWRU EM
Pulmonary Nodule
Evaluation is guided by nodule size & assessment of probability of malignancy. In addition is
Pulmonary Nodule Evaluation ... , clinical judgment ... The treatment of ... Management options ... imaging, positron emission
Malignant Hyperthermia Crisis - Guidelines for Crises in Anaesthesia
Unexplained increase in ETCO2 AND tachycardia AND increased
Malignant Hyperthermia ... Box D). ⓭ Plan admission ... to critical care ... therapy later DIC ... Checklist #Diagnosis #Management
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
accumulation of clinical ... Assessment • Clinical ... Autoimmune diseases: SLE ... inhibitors under evaluation ... Lymphohistiocytosis #diagnosis #management
Drug Induced Lupus (DIL)
 • Epidemiology: -10% of all lupus cases, drug-dependent, 4:1 to 1:1 F:M
to 1:1 F:M • Clinical ... , SCLE-DIL (terbinafine ... • Evolution: ... rheumatology #diagnosis #treatment ... #management
Polymyalgia Rheumatica (PMR) Diagnosis and Management Summary

WHAT?
 • Polymyalgia rheumatica (PMR) is a common systemic inflammatory
Diagnosis and Management ... • An evaluation ... arthropathies, myositis, malignancy ... greater than 6 dL ... TREATMENT: • The
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
overlaps with RA, SLE ... salivary ducts Clinical ... and Arthritis Malignancy ... Adenocarcinoma Treatment ... Rheumatology #Diagnosis #Management